InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc.

CRBP Clue Score27
United States Fiscal year ends December CIK 0001595097 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Cormorant Asset Management, LP
29 Oct 2026
Former 10% Owner
Sell indirect
425,000
$4.10
$1.74M
Yong Ben
14 Sep 2026
Director
Sold on a plan
2,000
$7.84
$15.68K
Nishant C Saxena
11 Aug 2026
Chief Business Officer
Buy
2,600
$9.63
$25.04K
Sean F. Moran
7 Aug 2026
Chief Financial Officer
Sold on a plan
12,000
$10.08
$120.97K
Yuval Cohen
7 Aug 2026
Chief Executive Officer
Sold on a plan
17,000
$10.08
$171.40K
John Kenneth Jenkins
10 Jun 2026
Director
Sold on a plan
4,800
$7.91
$37.99K
Anne Altmeyer
10 Jun 2026
Director
Sold on a plan
2,412
$7.91
$19.09K
Winston Kung
10 Jun 2026
Director
Sold on a plan
2,026
$7.91
$16.03K
Nishant C Saxena
3 Jun 2026
Chief Business Officer
Buy
9,000
$7.58
$68.22K
Nishant C Saxena
2 Jun 2026
Chief Business Officer
Buy
4,500
$7.33
$33.00K
Dominic Smethurst
2 Mar 2026
Chief Medical Officer
Sell
6,097
$8.30
$50.60K
Ian Hodgson
17 Feb 2026
Chief Operating Officer
Sell
847
$7.38
$6.25K
Yuval Cohen
13 Feb 2026
Chief Executive Officer
Sold on a plan
13,871
$7.78
$107.95K
Sean F. Moran
13 Feb 2026
Chief Financial Officer
Sold on a plan
4,701
$7.78
$36.59K
Ian Hodgson
3 Feb 2026
Chief Operating Officer
Sell
2,415
$8.09
$19.54K
Dominic Smethurst
3 Feb 2026
Chief Medical Officer
Sell
3,285
$8.09
$26.57K
Cormorant Asset Management, LP
11 Dec 2025
10% owner
Sell indirect
30,029
$11.46
$344.01K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 277,945
History held since 26 Nov 2014